Evidence map›Paper›PMID 18599527›Full record

ArticleDiabetes2008

Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36.

Pamela M Rogers, Nazar Mashtalir, Miloni A Rathod, Olga Dubuisson, Zhong Wang, Kumar Dasuri, Scott Babin, Alok Gupta, Nathan Markward, William T Cefalu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Human Adenovirus 36 Antibodies in Horses with Different Metabolic Statuses.Animals : an open access journal from MDPI · 2025
    Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. HIV Persistence in Adipose Tissue Reservoirs.Current HIV/AIDS reports · 2018
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Pamela M RogersPennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA.
Nazar Mashtalir
Miloni A Rathod
Olga Dubuisson
Zhong Wang
Kumar Dasuri
Scott Babin
Alok Gupta
Nathan Markward
William T Cefalu
Nikhil V Dhurandhar
Louisiana State University System · USPennington Biomedical Research Center · USWayne State University · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RIBNICKY, DAVID M · 2005 to 2019
$24.9M
Chromium and Insulin ActionR01DK060126 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI CEFALU, WILLIAM T. · 2003 to 2006
$1.7M
Mechanism of Promotion of Adipogenesis by Adenovirus-36R01DK066164 · NIDDK · WAYNE STATE UNIVERSITY · PI DHURANDHAR, NIKHIL V · 2004 to 2007
$755k
NCCIH NIH HHS P50 AT002776NCCIH NIH HHS P50AT002776-01NIDDK NIH HHS 1P30DK072476NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK060126NIDDK NIH HHS R01DK060126NIDDK NIH HHS R-01DK066164NIDDK NIH HHS R01 DK066164
6 · The paper itself

Abstract

objectiveExperimental infection of rats with human adenovirus type 36 (Ad-36) promotes adipogenesis and improves insulin sensitivity in a manner reminiscent of the pharmacologic effect of thiozolinediones. To exploit the potential of the viral proteins as a therapeutic target for treating insulin resistance, this study investigated the ability of Ad-36 to induce metabolically favorable changes in human adipose tissue. RESEARCH DESIGN AND

methodsWe determined whether Ad-36 increases glucose uptake in human adipose tissue explants. Cell-signaling pathways targeted by Ad-36 to increase glucose uptake were determined in the explants and human adipose-derived stem cells. Ad-2, a nonadipogenic human adenovirus, was used as a negative control. As a proof of concept, nondiabetic and diabetic subjects were screened for the presence of Ad-36 antibodies to ascertain if natural Ad-36 infection predicted improved glycemic control.

resultsAd-36 increased glucose uptake by adipose tissue explants obtained from nondiabetic and diabetic subjects. Without insulin stimulation, Ad-36 upregulated expressions of several proadipogenic genes, adiponectin, and fatty acid synthase and reduced the expression of inflammatory cytokine macrophage chemoattractant protein-1 in a phosphotidylinositol 3-kinase (PI3K)-dependent manner. In turn, the activation of PI3K by Ad-36 was independent of insulin receptor signaling but dependent on Ras signaling recruited by Ad-36. Ad-2 was nonadipogenic and did not increase glucose uptake. Natural Ad-36 infection in nondiabetic and diabetic subjects was associated with significantly lower fasting glucose levels and A1C, respectively.

conclusionsAd-36 proteins may provide novel therapeutic targets that remodel human adipose tissue to a more metabolically favorable profile.

Indexed as

Genetic TherapyAdenoviridaeAdenovirus Infections, HumanAdipose TissueAdultAntibodies, ViralDiabetes Mellitus, Type 2FemaleGlucoseHumansLipectomyMiddle AgedPhosphatidylinositol 3-Kinasesras ProteinsReceptor, InsulinSignal TransductionAntibodies, ViralGlucosePhosphatidylinositol 3-Kinasesras ProteinsReceptor, Insulin

Identifiers

PMID18599527
PMCPMC2518483
OpenAlexW2166945900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.